Literature DB >> 28129261

Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system.

Jeffrey F Barletta1, Alicia J Mangram, Marilyn Byrne, Joseph F Sucher, Alexzandra K Hollingworth, Francis R Ali-Osman, Gina R Shirah, Michael Haley, James K Dzandu.   

Abstract

BACKGROUND: Augmented renal clearance (ARC) is common in trauma patients and associated with subtherapeutic antimicrobial concentrations. This study reported the incidence of ARC, identified ARC risk factors, and described a model to predict ARC (i.e., ARCTIC) that is specific to trauma patients.
METHODS: Consecutive trauma patients who were admitted to the intensive care unit between March 2015 and January 2016 and had a measured creatinine clearance (CrCl) were considered for inclusion. Patients were excluded if their serum creatinine (SCr) was greater than 1.3 mg/dL. ARC was defined as a measured CrCl of 130 mL/min or greater. Demographic and trauma-specific variables were then compared, and multivariate analysis was performed. Using these results, a weighted scoring system was constructed and evaluated using receiver operating characteristic curve analysis. ARCTIC score cutoffs were chosen based on sensitivity, specificity, positive predictive value, and negative predictive value. The derived scoring system was then compared to a previously published scoring system for accuracy.
RESULTS: There were 133 patients with a mean age of 48 ± 19 years and SCr of 0.8 ± 0.2 mg/dL. The mean measured CrCl was 168 ± 65 mL/min, and the incidence of ARC was 67%. Multivariate analysis revealed the following risk factors for ARC (age, <56: odds ratios [OR], 58.3; 95% confidence interval [CI], 5.2-658.9; age, 56 to 75: OR, 13.5; 95% CI, 1.2-151.7), SCr less than 0.7 mg/dL (OR, 12.5; 95% CI, 3-52.6), and male sex (OR, 6.9; 95% CI, 1.9-24.9). Using these results, the ARCTIC scoring system was: 4 points if younger than 56 years, 3 points if aged 56 years to 75 years, 3 points if SCr less than 0.7 mg/dL, and 2 points if male sex. Receiver operating characteristic curve analysis revealed an area (95% CI) of 0.813 (0.735-0.892) (p < 0.001). An ARCTIC score of 6 or higher had a sensitivity, specificity, positive predictive value, and negative predictive value of 0.843, 0.682, 0.843, and 0.682, respectively.
CONCLUSION: The incidence of ARC in trauma patients is high. The ARCTIC score represents a practical, pragmatic system that can be easily applied at the bedside. An ARCTIC score of 6 or higher represents an appropriate cutoff to screen for ARC where antimicrobial adjustments should be considered. LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28129261     DOI: 10.1097/TA.0000000000001387

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  16 in total

1.  Augmented renal clearance: a common condition in critically ill children.

Authors:  Tatjana Van Der Heggen; Evelyn Dhont; Harlinde Peperstraete; Joris R Delanghe; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

2.  Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.

Authors:  Idoia Bilbao-Meseguer; Alicia Rodríguez-Gascón; Helena Barrasa; Arantxazu Isla; María Ángeles Solinís
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

3.  Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study.

Authors:  Emily Bing; Kym Archambault; Alice Sananikone; Kim-Dan Nguyen; Yi Tong Fang; Caren Jabamikos; Cécile Gras; Amélie Marsot; Marc-Alexandre Duceppe; Marc M Perreault
Journal:  Int J Clin Pharm       Date:  2022-07-14

4.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

Review 5.  Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing.

Authors:  Sherif Hanafy Mahmoud; Chen Shen
Journal:  Pharmaceutics       Date:  2017-09-16       Impact factor: 6.321

6.  Outcomes in patients with infections and augmented renal clearance: A multicenter retrospective study.

Authors:  Yasumasa Kawano; Junichi Maruyama; Ryo Hokama; Megumi Koie; Ryotaro Nagashima; Kota Hoshino; Kentaro Muranishi; Maiko Nakashio; Takeshi Nishida; Hiroyasu Ishikura
Journal:  PLoS One       Date:  2018-12-10       Impact factor: 3.240

7.  Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study.

Authors:  Cédric Carrié; Grégoire Chadefaux; Noémie Sauvage; Hugues de Courson; Laurent Petit; Karine Nouette-Gaulain; Bruno Pereira; Matthieu Biais
Journal:  Crit Care       Date:  2019-11-27       Impact factor: 9.097

8.  Assessment of acute kidney injury in neurologically and traumatically injured intensive care patients receiving large vancomycin doses.

Authors:  Casey C May; Beth L Erwin; Margaret Childress; Josh Cortopassi; Garrett Curtis; Tyson Kilpatrick; Jennifer Taylor; Bonnie Vance; Doug Wylie
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Oct-Dec

9.  Augmented renal clearance: a retrospective, cohort study of urinary creatinine clearance in critically ill patients in the United Kingdom.

Authors:  Brian W Johnston; David Perry; Martyn Habgood; Miland Joshi; Anton Krige
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

10.  Augmented Renal Clearance Following Traumatic Injury in Critically Ill Patients Requiring Nutrition Therapy.

Authors:  Roland N Dickerson; Christin N Crawford; Melissa K Tsiu; Cara E Bujanowski; Edward T Van Matre; Joseph M Swanson; Dina M Filiberto; Gayle Minard
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.